Among these five genes, ZFHX3 and RANBP2 are associated with an alternative mutation frequency among various malignant tumors (such as endometrial cancer and prostate cancer) (Packham et al., 2015; Walker et al., 2015; Hu et al., 2019). This evidence concerns the gene RANBP2 and endometrial cancer.